71 related articles for article (PubMed ID: 20600897)
1. A useful cell system for studying the regulation of 17HSD/KSR type 2 activity and expression in ovarian epithelial cancer.
Provost PR; Lima PH; Tremblay Y; Blomquist CH
J Steroid Biochem Mol Biol; 2010 Oct; 122(4):295-301. PubMed ID: 20600897
[TBL] [Abstract][Full Text] [Related]
2. Androgenic and estrogenic 17beta-hydroxysteroid dehydrogenase/17-ketosteroid reductase in human ovarian epithelial tumors: evidence for the type 1, 2 and 5 isoforms.
Blomquist CH; Bonenfant M; McGinley DM; Posalaky Z; Lakatua DJ; Tuli-Puri S; Bealka DG; Tremblay Y
J Steroid Biochem Mol Biol; 2002 Aug; 81(4-5):343-51. PubMed ID: 12361724
[TBL] [Abstract][Full Text] [Related]
3. 17beta-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; nomenclature and main characteristics of the 17HSD/KSR enzymes.
Peltoketo H; Luu-The V; Simard J; Adamski J
J Mol Endocrinol; 1999 Aug; 23(1):1-11. PubMed ID: 10431140
[TBL] [Abstract][Full Text] [Related]
4. Enzymes as modulators in malignant transformation.
Vihko P; Herrala A; Härkönen P; Isomaa V; Kaija H; Kurkela R; Li Y; Patrikainen L; Pulkka A; Soronen P; Törn S
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):277-83. PubMed ID: 15860271
[TBL] [Abstract][Full Text] [Related]
5. Characterization of 17beta-hydroxysteroid dehydrogenase isoenzyme expression in benign and malignant human prostate.
Elo JP; Akinola LA; Poutanen M; Vihko P; Kyllönen AP; Lukkarinen O; Vihko R
Int J Cancer; 1996 Mar; 66(1):37-41. PubMed ID: 8608963
[TBL] [Abstract][Full Text] [Related]
6. 17Beta-hydroxysteroid dehydrogenases in normal human mammary epithelial cells and breast tissue.
Miettinen M; Mustonen M; Poutanen M; Isomaa V; Wickman M; Söderqvist G; Vihko R; Vihko P
Breast Cancer Res Treat; 1999 Sep; 57(2):175-82. PubMed ID: 10598044
[TBL] [Abstract][Full Text] [Related]
7. Proliferative responses to altered 17beta-hydroxysteroid dehydrogenase (17HSD) type 2 expression in human breast cancer cells are dependent on endogenous expression of 17HSD type 1 and the oestradiol receptors.
Jansson A; Gunnarsson C; Stål O
Endocr Relat Cancer; 2006 Sep; 13(3):875-84. PubMed ID: 16954436
[TBL] [Abstract][Full Text] [Related]
8. Sex steroid metabolism in human gastric mucosa: 17 beta-hydroxysteroid dehydrogenase type 2 in normal, inflamed and neoplastic gastric tissues.
Oduwole OO; Mäkinen JM; Isomaa VV; Karttunen TJ; Vihko PT
Anticancer Res; 2003; 23(5A):3889-97. PubMed ID: 14666693
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acids increase 17 beta-hydroxysteroid dehydrogenase type 1 expression in JEG-3 and T47D cells, but the stimulation is potentiated by epidermal growth factor, 12-O-tetradecanoylphorbol-13-acetate, and cyclic adenosine 3',5'-monophosphate only in JEG-3 cells.
Piao YS; Peltoketo H; Jouppila A; Vihko R
Endocrinology; 1997 Mar; 138(3):898-904. PubMed ID: 9048588
[TBL] [Abstract][Full Text] [Related]
10. Steroid-converting enzymes in human ovarian carcinomas.
Chura JC; Ryu HS; Simard M; Poirier D; Tremblay Y; Brooker DC; Blomquist CH; Argenta PA
Mol Cell Endocrinol; 2009 Mar; 301(1-2):51-8. PubMed ID: 18723074
[TBL] [Abstract][Full Text] [Related]
11. Expression profiles of 290 ESTs mapped to chromosome 3 in human epithelial ovarian cancer cell lines using DNA expression oligonucleotide microarrays.
Manderson EN; Mes-Masson AM; Novak J; Lee PD; Provencher D; Hudson TJ; Tonin PN
Genome Res; 2002 Jan; 12(1):112-21. PubMed ID: 11779836
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of estrogen-metabolizing 17 beta-hydroxysteroid dehydrogenase type 2 expression correlates inversely with Ki67 proliferation marker in colon-cancer development.
Oduwole OO; Isomaa VV; Nokelainen PA; Stenbäck F; Vihko PT
Int J Cancer; 2002 Jan; 97(1):1-6. PubMed ID: 11774236
[TBL] [Abstract][Full Text] [Related]
13. Microarray analysis of gene expression mirrors the biology of an ovarian cancer model.
Tonin PN; Hudson TJ; Rodier F; Bossolasco M; Lee PD; Novak J; Manderson EN; Provencher D; Mes-Masson AM
Oncogene; 2001 Oct; 20(45):6617-26. PubMed ID: 11641787
[TBL] [Abstract][Full Text] [Related]
14. Patterns of expression of chromosome 17 genes in primary cultures of normal ovarian surface epithelia and epithelial ovarian cancer cell lines.
Presneau N; Mes-Masson AM; Ge B; Provencher D; Hudson TJ; Tonin PN
Oncogene; 2003 Mar; 22(10):1568-79. PubMed ID: 12629520
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome analysis of serous ovarian cancers identifies differentially expressed chromosome 3 genes.
Birch AH; Quinn MC; Filali-Mouhim A; Provencher DM; Mes-Masson AM; Tonin PN
Mol Carcinog; 2008 Jan; 47(1):56-65. PubMed ID: 17620309
[TBL] [Abstract][Full Text] [Related]
16. 17Beta-hydroxysteroid dehydrogenase type 2: independent prognostic significance and evidence of estrogen protection in female patients with colon cancer.
Oduwole OO; Mäkinen MJ; Isomaa VV; Pulkka A; Jernvall P; Karttunen TJ; Vihko PT
J Steroid Biochem Mol Biol; 2003 Nov; 87(2-3):133-40. PubMed ID: 14672733
[TBL] [Abstract][Full Text] [Related]
17. Human 17 beta-hydroxysteroid dehydrogenase type 1 and type 2 isoenzymes have opposite activities in cultured cells and characteristic cell- and tissue-specific expression.
Miettinen MM; Mustonen MV; Poutanen MH; Isomaa VV; Vihko RK
Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):839-45. PubMed ID: 8615778
[TBL] [Abstract][Full Text] [Related]
18. Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGFbeta-RII, KRAS2, TP53 and/or CDNK2A.
Samouëlian V; Maugard CM; Jolicoeur M; Bertrand R; Arcand SL; Tonin PN; Provencher DM; Mes-Masson AM
Cancer Chemother Pharmacol; 2004 Dec; 54(6):497-504. PubMed ID: 15258697
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells.
Ahluwalia A; Hurteau JA; Bigsby RM; Nephew KP
Gynecol Oncol; 2001 Aug; 82(2):299-304. PubMed ID: 11531283
[TBL] [Abstract][Full Text] [Related]
20. Mouse 17 beta-hydroxysteroid dehydrogenase type 2 mRNA is predominantly expressed in hepatocytes and in surface epithelial cells of the gastrointestinal and urinary tracts.
Mustonen MV; Poutanen MH; Kellokumpu S; de Launoit Y; Isomaa VV; Vihko RK; Vihko PT
J Mol Endocrinol; 1998 Feb; 20(1):67-74. PubMed ID: 9513083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
